Posted by Clinical Lab Products | Aug 2, 2005 | Cancer, Miscellaneous |
By Renee DiIulio Without oxygen, we would all die. Without hemoglobin, the protein that helps transport oxygen throughout our bodies, we would still die. With malfunctioning hemoglobin, as in the case of patients diagnosed with sickle cell diseas
Read MorePosted by Clinical Lab Products | Jul 11, 2005 | Cancer, Miscellaneous |
Leica Technology Makes Hollywood DebutIB An episode of “CSI: NY” recently aired in which the Leica AS LMD laser microdissection system played a major role in the development and conclusion of the story’s plot. The Leica AS LMD is
Read MorePosted by Clinical Lab Products | May 2, 2005 | Allergy & Autoimmune, Cancer |
By Gary Tufel Rheumatoid arthritis (RA) is a chronic, debilitating disease that affects 1% of the US population—about 2.1 million Americans. Currently, the cause of RA is unknown, although there are several theories. While there is no cure,
Read MorePosted by Clinical Lab Products | Apr 10, 2005 | Cancer, Miscellaneous |
COLA Announces New QMS Accreditation Program COLA has launched a quality management systems (QMS) accreditation program to assist laboratories faced with the challenge of maintaining a culture of quality. The program is a systems-based management
Read MorePosted by Clinical Lab Products | Feb 6, 2005 | Cancer, Miscellaneous |
By Nicholas Borgert Widespread use of the fibrous silicate material asbestos may be on its way out, but concern about the diseases it causes has caught the eye of at least one test developer: Fujirebio Diagnostics Inc (FDI). Asbestos has been u
Read More